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Abstract: The purpose of this review is to provide an overview of the current state of knowledge 
regarding the experience of intimate partner violence (IPV) during pregnancy.   Pregnancy IPV 
is a significant problem worldwide, with rates varying significantly by country and maternal 
risk factors. Pregnancy IPV is associated with adverse newborn outcomes, including low birth 
weight and preterm birth. Many mechanisms for how IPV may impact birth outcomes have 
been proposed and include direct health, mental health, and behavioral effects, which all may 
interact. Screening for IPV during pregnancy is essential, yet due to time constraints and few 
clear recommendations for assessment, many prenatal providers do not routinely inquire about 
IPV , or even believe they should. More training is needed to assist health care providers in 
identifying and managing pregnancy IPV , with additional research needed to inform effective 
interventions to reduce the rates of pregnancy IPV and resultant outcomes.
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Introduction
Intimate partner violence (IPV) is the currently accepted term used to describe what 
has been referred to as “woman abuse,” “woman battering,” or “domestic violence.” 
IPV has been defined as “repeated physical and/or sexual assault by an intimate partner 
within the context of coercive control.”1 While this definition recognizes the role of the 
intimate partner and the role of control, it excludes non-physical violence, an aspect 
of IPV often overlooked by health care providers and public health professionals.2 The 
US National Institutes of Mental Health Committee on Family Violence has proposed a 
broader description of IPV as “acts that are physically and emotionally harmful or that 
carry the potential to cause physical harm … [and] may also include sexual coercion 
or assaults, physical intimidation, threats to kill or harm, restraint of normal activities 
or freedom, and denial of access to resources.”3 This latter definition includes the three 
primary types of IPV recognized in the literature: physical, sexual, and emotional/
psychological/verbal violence.4 Intentional use of physical force is encompassed in 
“physical violence,” and use of force to compel a person to engage in a sexual act is 
what is referred to as “sexual violence.”5 “Emotional,” “psychological,” or “verbal” 
violence includes threats, humiliation, control of activities, isolation, name calling, 
and attempts to frighten.6
The purpose of this review is to provide an overview of the current state of knowl-
edge regarding the experience of intimate partner violence during pregnancy. It is our 
hope that this paper will provide useful information for researchers, health care provid-
ers, and policy makers. Findings from research conducted in countries throughout the  International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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world are described including information on the prevalence 
of pregnancy IPV , known effects, available screening meth-
ods, and management of this important health concern. The 
research reviewed was limited to English language reports. 
Preference was given to reports of large scale quantitative 
studies published in peer reviewed journals. However, some 
government reports were used, as were a few smaller scale and 
qualitative studies. This was necessary in order to provide the 
most accurate and up to date prevalence data and screening/
management recommendations, and to insure inclusion of 
information about pregnancy IPV in developing countries. 
As a result, however, conclusions drawn throughout this 
paper reflect the subjective interpretation of the author and 
the authors of other cited published papers. While a handful 
of systematic reviews of the literature have been published 
on various subtopics covered in this paper, a large scale 
comprehensive systematic review is still needed in order to 
draw specific and completely evidence-based conclusions 
formulated from comparisons of level of evidence and sci-
entific rigor across available studies.
Prevalence
General
IPV is a significant medical, public health, and societal con-
cern worldwide.7–9 Total annual health care costs related to 
IPV run into the billions in the United States,10,11 and IPV 
accounts for 20% of all violent crime.12 Twenty years ago, 
the US Surgeon General identified IPV as a public health 
problem of “epidemic” proportions.13 Reducing the rate of 
violence by current and former partners is one objective 
of the US Public Health Service’s Healthy People 2010 
  initiative.14 This is not surprising when the prevalence of IPV 
is   examined. The US Department of Justice estimates that 
over a lifetime, 52% of women experience IPV .15 In addi-
tion, 45% of those abused also report having been forced to 
have sex with their intimate partner.16 Anywhere from 1.5 to 
4 million US women are victimized by an intimate partner 
each year.17,18 Studies of female patients seeking health care 
have reported prevalences of 19%–33% for physical or sexual 
abuse,19,20 and 19%–66% for any form of IPV .17,21,22 Indeed, 
IPV is the leading cause of injuries and death among US 
women of childbearing age.23
Data on prevalence rates of IPV in other countries are 
also available. In a 2005 national Australian population 
study, 15% of women reported having experienced physical 
or sexual abuse in an intimate relationship.24 A Canadian 
study conducted with female family practice patients revealed 
a current or recent rate of any type of IPV of 15%,25 while 
a similar study in Spain found a 32% lifetime prevalence of 
any type of IPV .26 In Ukraine, a national survey put the rate 
of ever experiencing any type of IPV in a current relationship 
at 20%.27 A study of women seeking medical care in Rwanda 
revealed a life time prevalence of IPV at 35%,28 while similar 
figures from Nicaragua range from 40% to 52%.29 Finally, a 
study of women in Peru produced a lifetime IPV prevalence 
rate of 45%,30 while 35% of women who participated in a 
national health survey in India reported ever having expe-
rienced IPV .31 Recent findings from ten countries with data 
collected using a standardized instrument revealed a physical 
or sexual IPV lifetime prevalence from 15% to 71%,32 while a 
review of population-based studies around the world reported 
a 10%–15% lifetime physical IPV prevalence.33 Thus, it 
should not be surprising that one of the outcomes from the 
Fourth World Conference on Women (Beijing, 1995), was 
a call to encourage additional research on violence against 
women, including effective preventive measures, and an 
appeal to governmental and nongovernmental agencies to 
work to address IPV .34
Pregnancy
Researchers disagree about whether the prevalence of IPV 
decreases during pregnancy, remains about the same, or if 
a woman is at increased risk for IPV in the time between 
conception and delivery. Recent comprehensive reviews 
have generally concluded that while some hospital and 
clinic based studies noted an increased risk, national and 
international population-based studies have found either that 
pregnant women are no more likely than nonpregnant women 
to experience IPV , or may even be at decreased risk.35 Since 
research of violence during pregnancy currently accounts for 
20% of all reviewed nursing research,36 differing prevalence 
estimates abound. Gazmararian et al in a comprehensive 
review of the literature, concluded that the prevalence of 
IPV in pregnancy ranged from 1%–20%, depending on the 
way IPV is assessed and the population studied.7 Population 
based studies, including the US Centers for Disease Control 
and Prevention’s (CDC) Pregnant Risk Assessment Monitor-
ing System (PRAMS), which includes tens of thousands of 
women in 11 states, suggested the prevalence of pregnancy 
IPV is only 2.9%–5.7%.37 Similarly, a population-based 
study in New Zealand revealed a prevalence of pregnancy 
IPV of 9%.38
The problem with population-based studies of IPV is that 
while large and representative, the way IPV is assessed may 
lead to an underestimate of those affected. For example, those 
who participated in PRAMS were asked only a few general International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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questions about IPV . These questions were not behaviorally 
specific. In addition, the term “abused” was used, which may 
be regarded as demeaning or judgmental.39 Several projects 
have subsequently demonstrated that many women who claim 
they have not been “abused,” on specific follow-up question-
ing admit to experiencing violence.40,41
Several smaller-scale studies that included behaviorally 
specific questions have suggested much higher prevalence 
rates of IPV during pregnancy. Two US projects that 
included the Abuse Assessment Screen (AAS), a behav-
iorally specific measure described below, revealed a 10% 
prevalence of physical abuse during pregnancy.42,43 Yet 
another study of low risk women from private obstetric 
practices in the US revealed 11% had experienced abuse 
during pregnancy.44 A study of over 1,000 prenatal patients 
at public clinics in the US revealed 15% were abused during 
pregnancy,45 as did a study of nearly 1,000 women seek-
ing care in US family practice clinics who completed the 
AAS.46 Somewhat higher pregnancy IPV rates have been 
reported in Nicaragua,47 Turkey,48 and Pakistan,49 while 
similar or slightly lower rates have been noted in India50 
and Belgium.51
Several studies have included examination of prevalence 
rates of specific types of IPV . For example, 36% of patients 
at an obstetrics clinic in the US reported verbal abuse, 16% 
physical violence, and 14% reported severe physical vio-
lence when completing a modified AAS during pregnancy.52 
And in a US study that used an even more detailed and 
  behaviorally specific tool (the Conflict Tactics Scale, also 
described below), an incredible 81% of prenatal patients at 
a family practice clinic reported some type of IPV during 
pregnancy; 28% reported physical IPV , and 20% reported 
sexual   violence.53 These final studies highlight that preva-
lence disparities may in some cases be related to the type 
of tool used, and whether abuse includes verbal as well as 
physical abuse, and may partly explain differences in rates 
reported across studies. Based on findings from research 
like that presented above, some researchers have estimated 
that every year in the US, over 300,000 pregnant women 
experience IPV .54,55
Risk factors
As high as these rates are, the actual prevalence of IPV during 
pregnancy may be even higher due to reluctance of women to 
disclose IPV , especially during pregnancy.56 In addition, many 
studies have indicated certain women may be at increased risk 
of IPV during pregnancy due to socioeconomic status (SES), 
age, marital status, or minority status. While IPV can be found 
at all SES levels, many studies identify increased risk of IPV 
among both pregnant and nonpregnant lower SES women.57,58 
Population based studies also confirm the link between IPV 
and SES,59,60 as did analysis of the PRAMS data from pregnant 
women.61 A project involving 1000+ pregnant women in the 
US revealed that income and education levels were the most 
significant predictors of pregnancy violence.62 Similarly, a 
population-based study conducted in Chile, Egypt, India, 
and the Philippines demonstrated that socioeconomic indi-
cators were the most commonly and universally predictive 
factors of IPV .63
Younger women, those who are not married, and women 
from minority groups are also at increased risk for pregnancy 
IPV . Many reports have identified an association between 
younger age and pregnancy IPV ,64,65 with those abused up 
to four years younger on average.66 Some national survey 
reports suggest a nearly double risk of pregnancy IPV for 
women under 20.67 Similarly, single women are at increased 
IPV risk during pregnancy compared with married women,66 
with one study noting a fourfold increase in pregnancy IPV 
risk among single versus married women.67 Other character-
istics associated with increased risk include racial and ethnic 
background, especially minority status.41,62,66 In the United 
States in particular, Native American and African American 
women have an especially increased incidence of pregnancy 
IPV .68,69 These many and varied factors that are associated 
with a statistically increased likelihood of pregnancy IPV 
may also help explain the differing prevalence estimates 
described above. Clearly, studies with samples that consist 
of a large percentage of women with these “higher risk” 
characteristics will produce higher prevalence estimates than 
those studies with lower risk samples.
It is clear, then, that a substantial proportion of women 
worldwide have been victimized by an intimate partner. 
Whether pregnancy is a protective factor is unclear, 
however, expectant women across various studies and 
settings have reported significant levels of IPV. Rates of 
pregnancy IPV appear to differ across countries, although 
comparative conclusions are difficult due to differences in 
study methodologies. However, we know that many more 
women will report abuse when questions about psychologi-
cal victimization are included. Additionally, we know that 
while no groups of women can be considered immune from 
pregnancy IPV, certain characteristics are associated with an 
increased likelihood of this experience, and disproportion-
ate inclusion of higher risk women in studies will increase 
reported prevalence rates. In particular, younger minority 
women at the lower socioeconomic levels and who are  International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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unmarried are more likely than other women to experience 
IPV while pregnant.
Effects
Low birth weight and preterm delivery
The experience of IPV during pregnancy is associated with 
numerous negative consequences, including decreased infant 
birth weight and increased rates of prematurity. Low birth 
weight (LBW) and preterm births are leading causes of neo-
natal morbidity and mortality. Babies born before 37 com-
pleted weeks gestation are classified as preterm, while infants 
born weighing , 2,500 g are termed LBW. Prematurity and 
LBW often coexist, however 40% of all LBW babies are born 
at 37 weeks or later.70 These full term babies are referred to 
as small-for-gestational-age (SGA). Premature and low birth 
weight infants consume disproportionate amounts of scarce 
health care resources, and for those babies who survive pre-
maturity and low birth weight, adverse initial and long-term 
outcomes are common. In fact, an infant’s gestational age 
(GA) and birth weight at delivery are the strongest biologi-
cal predictors of immediate and long-term developmental 
outcomes.71 Research documents the long-term sequelae 
of extremely premature and LBW infants. Such children 
commonly have cognitive deficits, motor delays including 
cerebral palsy, academic difficulties, language delays, and 
significantly increased rates of attention problems, behavioral 
difficulties, and psychological problems.72–74 But even chil-
dren born at 32–36 weeks, or weighing 1,500–2,500 g, are 
at increased risk.75 Cognitive deficits, including neurological 
impairment,76 delayed mental development and decreased 
IQ,77–79 memory problems,80 and increased need for special 
education services81 are common. Attention, behavior, and 
psychological problems have also been linked to prematu-
rity, LBW, and SGA.79,82 Still other risks for preterm and 
LBW births are physical/biological, as several studies have 
documented permanent growth restriction for children born 
prematurely or with LBW.79,83 Further, poor general health 
well into childhood has been associated with SGA birth.84 
Specific health risks including an increased risk of sudden 
infant death syndrome,85,86 and increased severity of respi-
ratory synctial virus (RSV) infection for premature infants 
have been noted.87,88
It is apparent, then, that many and varied adverse out-
comes are associated with prematurity and LBW. Thus, that 
IPV during pregnancy might be linked to prematurity and 
LBW births is of great concern. Indeed, given such an asso-
ciation, it may be possible to reduce LBW and prematurity 
rates through interventions targeting IPV .89 Dozens of   studies 
have now been published that included an examination of 
the relationship between IPV and prematurity and LBW. 
Generalizations across studies are difficult due to differ-
ent populations, assessments, methods, and data analysis. 
However, over a dozen recent studies have identified sig-
nificant associations. An analysis of the US PRAMS data 
revealed a significant link between physical abuse during 
pregnancy and LBW.61 Reports of two other smaller scale 
studies also include significant associations between physi-
cal IPV during pregnancy and low birth weight,90,91 with one 
including a mean difference in birth weight of 164 g.90 And 
in another study, compared with non-abused women, those 
abused had significantly increased rates of preterm deliveries 
(22% vs 9%) and LBW babies (16% vs 6%).92 Research with 
women in China, South Africa, and Saudi Arabia revealed 
similar findings.93–95
Still other studies found significant associations 
between pregnancy IPV and newborn outcomes, even 
after control for background and other factors associated 
with either IPV and/or newborn outcomes. For example, 
among over 400 low income women, any form of IPV 
during pregnancy was associated with a 250 g decrease 
in infant birth weight, and this link remained significant 
even after control for sociodemographic factors includ-
ing prenatal care and stressors.96 Similarly, other studies 
have noted a two- to fourfold increase in the risk of LBW 
associated with pregnancy IPV after control for confound-
ing.58,97 Using police reported, rather than   self-reported 
IPV , significant negative associations between IPV and 
birth weight and gestational age at delivery were identi-
fied, even after control for sociodemographic   factors, 
adequacy of prenatal care utilization, and prenatal smok-
ing.98 A recent large-scale study revealed that physical 
injury due to IPV was associated with preterm birth and 
a 75 g reduction in birth weight, even after control for 
sociodemographics, prenatal substance use, pregnancy 
weight gain, and pregnancy complications.19 Interestingly, 
the authors report that when gestational age is controlled, 
the birth weight reduction is only 24 g, suggesting that 
most of the association between IPV and birthweight can 
be explained by a decrease in gestational age. Finally, a 
meta-analysis of eight methodologically sound and recent 
studies revealed a significant association between preg-
nancy IPV of any kind and newborn outcomes (pooled 
odds ratio of 1.4 for birth weight). The authors of this 
review concluded that due to the recent findings from 
analyses that included control for a multitude of factors, 
a relationship between IPV and newborn outcomes indeed International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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exists, but may be secondary to, or explained by, prenatal 
smoking, substance use, or inadequate pregnancy weight 
gain among other factors.89
Mechanisms for effects
So why might the experience of IPV lead to poor birth out-
comes? Many factors may explain the association including 
direct physical effects, and the impact on mental health and 
behavioral changes. For example, abuse involving abdominal 
trauma can lead to premature labor, rupture of membranes, 
placental abruption, and ruptured uterus, all of which lead 
to preterm birth or even fetal demise.99–102 IPV has also been 
associated with an increased incidence of urinary tract infec-
tions which have been associated with preterm birth.103–105 
Additionally, IPV during pregnancy may exacerbate chronic 
problems such as hypertension and gestational diabetes, both 
of which have implications for newborn outcomes.103,106 And 
finally, cervical and uterine infections, including HIV and 
other sexually transmitted diseases (STDs), occur at higher 
rates among abused pregnant women compared to those not 
abused,66,107 placing them at increased risk for intrauterine 
growth restriction and preterm birth.108–110
In addition to direct physical and health effects, pregnancy 
IPV has been associated with many mental health factors 
as well.111,112 Women who experience IPV either during or 
outside of pregnancy were found to have a ninefold increase 
in risk for a mood or anxiety disorder,113 to be significantly 
more likely to be hospitalized for mental health related 
problems,98 and half of the women referred to a rural mental 
health center by their health care provider turned out to be 
unrecognized battered women.114 Experience of mental health 
problems during pregnancy has in turn been associated with 
adverse   newborn outcomes.115 Depression has been identified 
as the most common mental health consequence of IPV ,116 
with nearly 40% of abused women reporting symptoms,117,118 
and depression in pregnancy has been linked to both preterm 
birth and LBW.119–121 In addition, other studies have shown that 
45% of women experiencing IPV were found to have posttrau-
matic stress disorder,118 with stress in pregnancy associated 
with both preterm birth and LBW in multiple projects.122–124 
These findings have led researchers to conclude that further 
work is needed to understand the role of depression and stress 
in the relation between IPV and preterm and low birth weight 
births,125,126 so that clinical practice might be better informed 
and appropriate interventions can be designed.127
Besides the effects IPV may have on physical or mental 
health, IPV has also been associated with many negative 
health behaviors during pregnancy, perhaps stemming at least 
in part from the associated mental health effects as described 
above. These behaviors, including inadequate prenatal care 
utilization, inadequate weight gain, and smoking, drink-
ing, and substance use during pregnancy, have in turn been 
associated with negative newborn outcomes. For example, 
one of the primary health behavior factors associated with 
both IPV and prematurity and LBW is inadequate prenatal 
care utilization. A link between IPV and late entry into 
prenatal care has been described in multiple reports,91,107,128 
with those experiencing IPV twice as likely to begin care 
in the third trimester,65,129 and entering care up to 6.5 weeks 
later,130 compared with other women. Additionally, women 
experiencing pregnancy IPV are significantly more likely 
than non-abused women to miss three or more prenatal visits 
(45% vs 28%).44
Much published research suggests inadequate prenatal 
care utilization is linked to poor neonatal outcomes.131 
In particular, studies involving higher risk populations 
(minorities, teenagers, lower SES) have revealed significant 
relations between prenatal care (timing of entry, number of 
visits, and adequacy of care utilization) and both infant birth 
weight and prematurity.132–135 Even in low risk populations, 
a link between prenatal care rates and prematurity136 and 
LBW137 has been noted.
Poor nutritional intake and inadequate weight gain have 
also been associated with both pregnancy IPV and adverse 
newborn outcomes. Several reports detail an association 
between pregnancy IPV and failure to gain weight.97,138 In fact, 
one study noted that history of physical IPV increases the risk 
of inadequate prenatal weight gain threefold.139 Additionally, 
many studies have identified an association between inad-
equate pregnancy weight gain or poor nutrition and adverse 
outcomes, including LBW.140–142 A recent study found that 
the relation between pregnancy IPV and infant birth weight 
was completely mediated by poor pregnancy weight gain,143 
and others have supported this contention.144
Smoking during pregnancy is another health factor 
linked to both IPV and newborn outcomes. Many studies 
have described an association between IPV and pregnancy 
smoking.45,66,107,138,145 Projects have reported that smoking par-
tially mediates the association between IPV and poor newborn 
outcomes,143 possibly due to the association between smoking 
and stress and depression.115,126,143 As had been reviewed,146,147 
prenatal cigarette exposure is associated with both LBW and 
prematurity. Dozens of studies have reported a link between 
prenatal cigarette exposure, and prematurity/LBW.148–151 
Effects are not limited to those heavily exposed. National 
statistics for 2002 reveal that 11.5% of babies born to light  International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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smokers (fewer than six cigarettes/day) were LBW, more than 
50% higher than the LBW rate for births to nonsmokers.145
Finally, alcohol and illicit substance use have also been 
implicated in the relationship between IPV and adverse 
newborn outcomes. Multiple projects have described an 
increased risk of alcohol and substance use among pregnant 
battered women.44,98,125,143 Indeed, up to 50% of alcoholism 
in women may be precipitated by abuse.152 Numerous stud-
ies have identified an association between prenatal alcohol 
and drug exposure and adverse newborn outcomes including 
prematurity and low birth weight.92,121,148,153–155
Clearly, the experience of IPV during pregnancy has 
many adverse consequences. Babies born to women who 
are subjected to IPV while pregnant have a significantly 
increased risk of being born preterm or LBW, which can 
result in immediate and long term health and developmental 
problems. Effects are not limited to women who experience 
only physical abuse or trauma, as even psychological IPV 
has been linked to poor pregnancy outcomes. Many maternal 
factors are associated with pregnancy IPV , including physical 
and mental health problems, and negative health behaviors. 
Causality has not been established, and thus the direction 
of these relationships is not known. However, knowledge 
of the maternal characteristics statistically associated with 
pregnancy IPV can provide useful information to clinicians 
attempting to identify women experiencing or risk for expe-
riencing IPV . Again, while any woman could be a potential 
victim, those most likely to be experiencing pregnancy IPV 
are women with recurrent pregnancy infections, including 
STDs, women who suffer from depression or anxiety, women 
with inadequate prenatal care utilization, those who fail to 
gain adequate weight, and women who smoke, consume 
alcohol, or use illicit substances during pregnancy. Knowl-
edge of these characteristics and related demographic factors 
described in the previous section, together with the use of 
validated IPV assessment tools described in the subsequent 
section, can aid health care providers in the identification of 
women most at risk for IPV .
Screening and management
Many professionals and organizations have addressed IPV by 
recommending universal screening and promoting zero toler-
ance for IPV . Nearly two decades ago, the American Medical 
Association recommended screening all women presenting to 
primary care and many secondary care specialties.156 Simi-
lar recommendations have been advanced by the American 
Academy of Family Physicians,157 the American College 
of Nurse-Midwives (ACNM),158 the Joint   Commission on 
Accreditation of Health Care Organizations,159 and the World 
Health Organization.160 The American College of Obstetri-
cians and Gynecologists (ACOG) has recommended that 
women be screened for IPV routinely at preconception, 
family planning, and gynecologic visits, as well as at the first 
prenatal visit, at least once per trimester, and at post partum 
checkup.161 Reinforcing their commitment to addressing 
IPV , ACOG sent material to all 28,000 members about IPV , 
including signs of abuse.162 ACOG and ACNM have been 
particularly proactive, as pregnancy may be the only time a 
woman will regularly access health care.128,163,164 In addition 
to the position statements of the professional organizations, 
based on the findings of their own and other studies, many 
researchers and clinicians have also advocated for universal 
IPV screening in health care settings.44,127,145,165
Screening attitudes and practices
Despite the recommendations, screening for IPV in health 
care settings in general, and during pregnancy in particular, 
is far from universal. Studies vary widely in findings related 
to whether providers believe they should screen and whether 
they actually do screen female patients for IPV . For example, 
a US survey of primary care resident physicians revealed that 
95% thought screening for IPV was ‘important.’166 A survey 
of Scottish midwives found only 66% thought they should 
ask patients about IPV ,167 while a study involving obstetri-
cians in Pakistan found just under half felt women should be 
routinely screened for IPV .168 Additionally, a British study 
revealed that only 15% of general practitioners and practice 
nurses felt they should be routinely asking about IPV .169 
In a survey of over 300 primary care physicians in the US, 
only 6.2% reported screening for IPV at initial visits, and 
only 7.5% did at annual exams.170 In other studies, anywhere 
from 10%–65% of US physicians report following ACOG 
screening guidelines for IPV during pregnancy.171–173 A study 
in Belgium revealed only 8% of gynecologists routinely 
screened for IPV ,167 while in a Canadian study, 42% of physi-
cians reported routinely screening for IPV .174 Unfortunately, 
surveys of patients themselves often result in even lower 
screening prevalence estimates. In two separate samples, 
only 6%175 and 18%176 of women recalled having been asked 
about IPV by their physician. This disconnect between what 
physicians say they do and what patients remember being 
asked was especially evident in a survey of physicians and 
their female patients, where 33% of physicians said they 
screen for IPV , while only 7% of their patients recall being 
asked about IPV .177 These and similar findings led the authors 
of a comprehensive review to conclude that the majority International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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of health care providers do not find a universal screening 
  program for IPV acceptable or practical, with acceptance 
rates ranging from 15%–95% across studies worldwide.178 
They did note, however, that acceptability of IPV screening 
was generally higher in the US than in other countries exam-
ined. Finally, because of these widely varying prevalence 
rates of acceptance and practice related to IPV screening, 
the CDC concluded in 2004 that the extent to which US cli-
nicians incorporate screening for IPV into their practices is 
relatively unknown.179 A comprehensive review on studies in 
dozens of countries reached a similar conclusion with respect 
to screening practice rates in other countries.178
Additional research has been conducted to investigate 
why, despite national policies and recommendations, health 
care providers are not screening all of their female patients, 
and pregnant women in particular, for IPV . Failure to screen 
is unfortunate, as a recent study revealed disclosure of IPV to 
increase from 5% to 30% after implementation of universal 
screening.180 Others have reported that when asked directly 
about IPV , most women will answer honestly if separated 
from their batterers.181 Multiple reasons for failure to screen 
have been advanced, including general provider unwillingness 
as described above. However, the most common barrier to 
IPV screening in health care settings appears to be time,182,183 
with as many as 46% of providers citing time constraints as 
the primary reason for not screening all female patients for 
IPV .184 Other reasons offered for failure to routinely screen 
for IPV include lack of confidence and personal discomfort, 
belief that women will not disclose abuse or seek help, and 
not knowing what to do if IPV is revealed.178 Additionally, 
most providers cite a lack of knowledge in IPV assessment. 
Indeed, in a recent US survey, 96% of physicians believed that 
training in domestic violence screening should be included in 
medical education,185 while a recent study in   Belgium revealed 
that fewer than 7% of gynecologists had ever received any 
education or training in IPV assessment.186
Unfortunately, even when health care providers do inquire 
about IPV , some women still do not disclose their   experiences. 
A Canadian study found that only 29% of women who experi-
enced IPV have discussed it with their health care provider.187 
Reasons for failure to disclose have been summarized in 
multiple papers and include fear of retaliation, being blamed, 
that others won’t understand, lack of confidentiality, losing 
their children, losing what little control they have, economic 
or psychological dependence on the abuser, and the promise 
of change.39,188 Despite this, certain circumstances increase 
the likelihood that women will disclose IPV to their health 
care providers including direct, repeated, and behaviorally 
specific questioning.7,20,21,173 As discussed previously, asking 
questions about specific behaviors, and avoiding terms such 
as “abuse” are key to accurate disclosure. For example, after 
being asked if they had been abused by their partner, 38% of 
women changed their answer from no to yes when follow-up 
questioning was behaviorally specific.116 In general, both 
abused and non-abused women don’t mind being asked, 
and in fact agree and expect that providers should screen 
women for IPV .189–192 In one study, 96% of a sample of over 
1,300 women asked prenatally felt ‘OK’ about being asked,192 
and in another study, it was actually the abused women who 
were 1.5 times more likely than those not abused to agree 
with universal screening.193 A recent comprehensive review 
on the topic concluded that most women found IPV screening 
in a health care setting acceptable, provided the health care 
professional was sensitive, nonjudgmental, and they did not 
feel the information revealed would be used to show they 
were not caring for their children properly.178 All of these 
findings have led researchers to conclude that if the impact 
of IPV is ever to be reduced, it is imperative that health care 
professionals routinely screen all women for IPV .4,143,163
Screening tools
Many health care provider attempts to screen for IPV involve 
asking only one question. Unfortunately, recent research has 
suggested that responses to single IPV items do not corre-
spond to scores on longer, standardized measures.194 In fact, 
in one study of prenatal patients, single item responses were 
completely unrelated to both verbal aggression (r = 0.03) 
and violence (r = −0.05) scales of the well validated Con-
flict Tactics Scale (CTS).195 The CTS,196 and the more recent 
modification the CTS2,197 have long been regarded as the gold 
standard of IPV assessment,198 and take 10–15 minutes to 
complete. While the original CTS2 asks questions about IPV 
based on occurrences in the past year, the authors permit use 
of other referent periods,197 and pregnancy studies typically 
ask about occurrences in the 12 months before pregnancy, 
and separately for occurrences since the beginning of preg-
nancy.145 Other IPV tools of similar length include the Index 
of Spouse Abuse,199 the Severity of Violence Against Women 
Scale,200 and the Abuse Risk Inventory.201
Due to the length of the CTS2 and other tools listed 
above, and the fact noted that providers often fail to screen 
due to time constraints, these tools are not practical for 
use in clinical settings. Even short versions contain, at a 
minimum, 24 items.197 Thus, many shorter IPV measures 
more appropriate for clinical use have been developed in 
the last two decades. The CDC have recently developed a  International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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compendium of brief partner violence assessment tools that 
are   recommended for use in health care settings.202 This 
publication includes dozens of tools, including information 
about their administration and psychometric properties, and 
is an excellent provider resource. Some of the more com-
monly used tools are described here. The five-item AAS,203 
is a commonly used IPV screen due to ease of administration 
and established reliability and validity.35 The AAS is most 
sensitive to major physical violence, but is less accurate in 
identifying women who have experienced minor physical 
or emotional abuse.178 In addition to the AAS, several other 
measures that screen for IPV are available. The seven-item 
Woman Abuse Screening Tool (WAST)204 was specifically 
designed for use in family practice settings to identify female 
patients experiencing emotional and/or physical abuse by 
their intimate partner (Appendix 1). While comprehensive for 
a screening tool, cut-points for determination of abuse have 
not been well validated.178 A similar measure, the four-item 
HITS,205 was designed by a focus group of family physicians 
for use in outpatient clinical settings (Appendix 2). HITS is 
an acronym, representing the four questions asking about 
“Hits,” “Insults,” “Threatens,” and “Screams,” making it 
easier for providers to remember. Questions are answered 
on a five-point scale, with a cut-off of 10.5 maximizing both 
sensitivity and specificity.178 In contrast to the AAS and HITS, 
which assess how much and to what degree IPV is occurring, 
the 15-item Danger Assessment scale (DA)116 measures risk 
of extreme consequences of IPV .
The US Preventive Service Task Force has concluded 
that there is still insufficient evidence to recommend one 
IPV screening tool over another.159 While further research is 
needed to determine the most appropriate and effective way 
to assess IPV in clinical settings,206 some comparative find-
ings have been published. A recent study of women’s prefer-
ences for IPV screening revealed the WAST to be preferable 
over other standardized tools.192 While acceptability of a tool 
to patients will likely increase disclosure, such data do not 
tell us about the reliability and validity of various screen-
ing tools. Feder and colleagues conducted a comprehensive 
review of dozens of studies from across the world, many of 
which involved comparisons of various screening tools to 
gold standards such as the CTS.178 They concluded that the 
HITS screening tool demonstrates the best predictive power, 
validity, and reliability, and is also the easiest for providers 
to remember. However, this tool does not ask about sexual 
abuse or ongoing violence, and thus may need to be com-
bined with another screening tool. They review authors also 
concluded that the WAST and AAS perform almost as well 
as the HITS in health care settings. Thus, it appears that any 
of these three tools could be effectively used by prenatal care 
providers to screen for IPV in their patients.
Management and intervention
While we are beginning to learn about the best way to screen 
for IPV during pregnancy, much less is known about how to 
effectively manage this problem once it is identified. Indeed, 
as described above, many providers do not routinely screen 
for IPV because they do not know what they should do if it 
is discovered. This is unfortunate as studies have revealed 
that disclosure of abuse in a health care setting, even in the 
absence of a subsequent intervention, can reduce the inci-
dence of additional violence.207 A recent survey of US physi-
cians, with obstetricians the largest specialty group included, 
examined attitudes about managing IPV in patients.208 Most 
responders (85%) felt the work was significant, although 
few (11%) had overall positive feelings about it. Most felt 
helping IPV victims was stressful, difficult, and risky. Addi-
tionally, the majority of respondents reported no or minimal 
training in addressing IPV with patients, and the majority 
scored below 80% on an IPV knowledge test. The study 
authors concluded that health care workers need additional 
training and support in order to effectively manage patients 
experiencing IPV .
Several options are available to health care providers in 
the management of patients, and pregnant women in particu-
lar, who are being abused. The first type is interventions for 
the women themselves. Health care providers with training 
in this area may be able to provide limited counseling in the 
form of a brief intervention or motivational interviewing. 
However, lack of time and experience precludes this option in 
the vast majority of cases. Other more commonly employed 
options are referrals to safe environments, including family 
members or shelters, referrals to counseling or other com-
munity based resources, and the provision of resource infor-
mation. Another set of intervention options is referral of the 
perpetrator to a batterer treatment program. The practicality 
of this approach is somewhat limited, however, if the provider 
has no contact with the abuser or the abuser is unwilling to 
seek help. However, along these lines, a woman who is being 
physically abused can be encouraged to file legal charges or 
seek a protective order.
Unfortunately, few published studies provide data to 
demonstrate the effectiveness of any of the above manage-
ment options. One exception is a report on a US intervention 
project involving six telephone calls from a nurse over an 
eight-week period in which safety-promoting behaviors were International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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discussed.209 Compared to controls, women who received the 
phone calls engaged in significantly more safety-promoting 
behaviors at follow-up. A handful of reports can be found on 
projects outside the US and Europe. One is an initial report on 
an IPV intervention implemented in Australia which focused 
on the provision of a community mentor to provide assistance, 
support, and advocacy.210 While preliminary data suggest 
this approach is somewhat effective, final data are not yet 
available. A second report is from a study in Nicaragua with 
an intervention focused simply on inquiring about possible 
IPV discussing attitudes toward it.47 While the majority of 
women reported that their abuse had ended at follow-up, no 
control group was used in this study, limiting the usefulness 
of the findings.
Two recent reviews have attempted to synthesize what 
we know about the effectiveness of treatment options 
in North America and Europe for women experiencing 
IPV . The first was conducted by Wathen and MacMillan, 
published in 2003.211 They reviewed management options 
for both the victim and the abuser. In terms of studies on 
interventions for women, most involved examining the 
effectiveness of shelter stays, advocacy counseling, personal 
and vocational counseling, and enhanced prenatal counsel-
ing addressing IPV. The highest quality rating of any of the 
studies was “fair,” indicating that outcomes were based on 
self-report and/or tools used were of uncertain validity. 
While all studies reviewed had methodological weaknesses, 
some conclusions could be drawn. First, no current evidence 
of suitable quality exists to evaluate the effectiveness of a 
shelter stay to decrease the incidence of violence. While 
this does not mean that a shelter stay may not be useful 
for some abused women, further research is needed to 
more definitely evaluate the effectiveness of this option. 
However, there was fair evidence to suggest that a shelter 
stay combined with advocacy counseling can decrease the 
rate of re-abuse and improve quality of life over the next 
two years.211 Thus, it appears that health care providers may 
be able to effectively manage IPV in their female patients, 
and pregnant patients in particular, by becoming aware 
of both shelter and advocacy programs in their area, and 
encouraging patients they identify as experiencing IPV to 
use these services.
The Wathen and MacMillan review211 also examined 
studies that targeted male batterers, either alone or with their 
partners. These interventions have been more thoroughly 
studied, and thus evidence about their effectiveness is more 
readily available. Unfortunately, most programs that work 
with abusers to decrease the incidence of IPV have not been 
shown to be effective. In contrast, there is some evidence to 
suggest that arrest of the perpetrator, and the use of protec-
tive orders, can be effective in some cases. However, there is 
also data demonstrating that in some cases this approach can 
actually lead to an escalation of violence, especially when 
the perpetrator is unemployed or otherwise has little to lose 
by not complying with the legal system. Finally, initial data 
suggest that protection orders combined with legal advocacy 
and counseling may reduce the incidence of re-perpetration 
for many men. Thus, health care providers can also help to 
manage IPV in patients by having information available 
about the legal system and local options for assistance for 
batterers.
A more recent Cochrane review, conducted by Ramsay 
and colleagues,212 specifically examined the effectiveness of 
IPV interventions for women that involved advocacy. Ten 
studies were found that met inclusion criteria, and all dif-
fered in type and intensity of advocacy, outcomes assessed, 
and duration of follow-up. Overall, they found that intensive 
advocacy (12 hours or more total) as part of or after a shelter 
stay improved quality of life at up to 12 months follow-up, 
and increased the chances of termination of physical abuse 
at up to 24 months follow up. Intensive advocacy was not 
found to impact either depression or psychological distress. 
Minimal data were available to definitively evaluate the 
effectiveness of brief advocacy interventions, but evidence 
suggests they do increase the use of safety behaviors both 
short and long term, even for women who remain with the 
perpetrator. However, the authors conclude that while inten-
sive advocacy is likely to be most effective, further research 
is needed to determine the utility of briefer advocacy inter-
ventions, both for women who leave or who remain with the 
perpetrating partner.212
Conclusion
It is clear that pregnancy IPV is a significant problem world-
wide and is associated with adverse newborn outcomes. Many 
mechanisms for how IPV may impact LBW and preterm 
births have been proposed and include direct health, mental 
health, and behavioral effects, all of which may help providers 
identify women most at risk. Screening for IPV during preg-
nancy is essential, yet due to time constraints and few clear 
recommendations for assessment, many prenatal providers 
do not routinely inquire about IPV . More training is needed 
to assist health care providers in identifying and managing 
pregnancy IPV , with additional research needed to inform 
effective interventions to reduce the rates of pregnancy IPV 
and resultant outcomes. International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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Appendix 1
Woman Abuse Screening Tool (WAST) 
from Brown and Ryan204
1.  In general, how would you describe your relationship?
A lot of tension (2)  Some tension (1)  No tension (0)
2.  Do you and your partner work out arguments with…
Great Difficulty (2)  Some Difficulty (1)   
  No difficulty (0)
3.  Do arguments ever result in you feeling put down or bad 
about yourself?
Often (2)  Sometimes (1)  Never (0)
4.  Do arguments ever result in hitting, kicking, or 
pushing?
Often (2)  Sometimes (1)  Never (0)
5.  Do you ever feel frightened by what your partner says or 
does?
Often (2)  Sometimes (1)  Never (0)
6.  Has your partner ever abused you physically?
Often (2)  Sometimes (1)  Never (0)
7.  Has your partner ever abused you emotionally?
Often (2)  Sometimes (1)  Never (0)
Appendix 2
HITS Scale: Hurts, Insults, Threatens, 
Screams from Sherin et al205
Please respond to the questions below using the following 
scale:
1 = Never
2 = Rarely
3 = Sometimes
4 = Fairly often
5 = Frequently
Since you were pregnant, has a partner or ex-partner…
_____ 1. Physically hurt you?
_____ 2. Insulted you fairly often?
_____ 3. Threatened you?
_____ 4. Screamed at you fairly often?